Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and UpdateKaplan HeraldCAMBRIDGE, Mass., March 06, 2018 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:), a leading genome editing company, today reported financial results for the f… Continue reading
Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and UpdateKaplan HeraldCAMBRIDGE, Mass., March 06, 2018 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:), a leading genome editing company, today reported financial results for the f… Continue reading
Proactive Investors UKWideCells Group clinches deal to launch stem cell insurance product in AsiaProactive Investors UKJoão Andrade, WideCells chief executive, commented: "With over 250,000 clients, established operations in three countries and ar… Continue reading
Proactive Investors UKWideCells Group clinches deal to launch stem cell insurance product in AsiaProactive Investors UKJoão Andrade, WideCells chief executive, commented: "With over 250,000 clients, established operations in three countries and ar… Continue reading
The Big Smoke AustraliaUK stem cell trial could restore sight to the impairedThe Big Smoke AustraliaThis deterioration in sight is caused when a thin layer of light-sensing retinal cells at the back of the eye, in a region called the macular, dies. And… Continue reading
The time has come for gene therapy to treat retinal disease, AMDModernMedicineComing off the heels of the first ocular gene therapy approved in the United States, Szilard Kiss, MD, pointed out that the gene therapy era for retinal disease has arrived, … Continue reading
Week HeraldAnalyzing NewLink Genetics (NASDAQ:NLNK) & Editas Medicine (EDIT)Week HeraldIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonuc… Continue reading
Comparing Editas Medicine (EDIT) and NewLink Genetics (NLNK)StockNewsTimesIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) c… Continue reading